Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4062556
Max Phase: Preclinical
Molecular Formula: C21H21BrN4OS
Molecular Weight: 457.40
Molecule Type: Small molecule
Associated Items:
ID: ALA4062556
Max Phase: Preclinical
Molecular Formula: C21H21BrN4OS
Molecular Weight: 457.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)C1CCc2c(sc3c2c(=O)n(-c2ccc(Br)cc2)c2nncn32)C1
Standard InChI: InChI=1S/C21H21BrN4OS/c1-21(2,3)12-4-9-15-16(10-12)28-19-17(15)18(27)26(20-24-23-11-25(19)20)14-7-5-13(22)6-8-14/h5-8,11-12H,4,9-10H2,1-3H3
Standard InChI Key: OWXGWGMHJIVJPT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.40 | Molecular Weight (Monoisotopic): 456.0619 | AlogP: 5.01 | #Rotatable Bonds: 1 |
Polar Surface Area: 52.19 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.72 | CX LogD: 5.72 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.40 | Np Likeness Score: -1.76 |
1. Kumar Biswas B, Malpani YR, Ha N, Kwon DH, Soo Shin J, Kim HS, Kim C, Bong Han S, Lee CK, Jung YS.. (2017) Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones., 27 (15): [PMID:28587824] [10.1016/j.bmcl.2017.05.030] |
Source(1):